戻る Agenda
From Opportunity to Strategy: Introducing Intelligent Automation Technologies within Pharmacovigilance for the ICSR Process
Session Chair(s)
Raymond Kassekert, MBA
Senior Director PV Systems
GSK, United States
Intelligent automation can transform the ICSR process. We discuss how to pair opportunities with available technologies for this process, and how a validation strategy may vary based on the proposed automation for a given ICSR process step.
Learning Objective : Recognize available PV automation technologies as they relate to opportunities and the current PV technology landscape within the ICSR process; Describe how to plan future use of intelligent automation based on risks, benchmarking, and potential benefit; Describe how to educate colleagues on possible opportunities, areas worth exploring for further transformation, possible technology solutions, and validation strategy.
Speaker(s)
Introducing Intelligent Automation Technologies within Pharmacovigilance for the ICSR Process
Sameen Desai, MBA, MS
Bristol-Myers Squibb Company, United States
Executive Director, IT Worldwide Patient Safety
Introducing Intelligent Automation Technologies within Pharmacovigilance for the ICSR Process
Neal Grabowski, MBA, MS
Sanofi, United States
TransCelerate IAO Workstream Lead; Head, Signal Management
Introducing Intelligent Automation Technologies within Pharmacovigilance for the ICSR Process
Griselda Saldana, MSc
Amgen AB, United States
PV Ops